Antagonism between long acting Monoamine Oxidase Inhibitors (MAOI) and MD780515, a new specific and reversible MAOI
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 26 (25) , 2165-2171
- https://doi.org/10.1016/0024-3205(80)90604-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated ratsLife Sciences, 1978
- Phenylethylamine—Deamination by multiple types of monoamine oxidaseBiochemical Pharmacology, 1978
- Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamineBiochemical Pharmacology, 1978
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- Multiple forms of monoamine oxidase: Fact and artefactLife Sciences, 1976
- Rates of recovery of irreversibly inhibited monoamine oxidases: A measure of enzyme protein turnoverNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- A sensitive and specific assay for the estimation of monoamine oxidaseBiochemical Pharmacology, 1963
- Antagonism between harmaline and long-acting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brainCellular and Molecular Life Sciences, 1959
- Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compoundsBiochemical Pharmacology, 1958